Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiondisaccharide binding

LGALS9C LGALS9B LGALS9

1.20e-067663GO:0048030
GeneOntologyMolecularFunctiongalactoside binding

LGALS9C LGALS9B LGALS9

2.86e-069663GO:0016936
GeneOntologyMolecularFunctionoligosaccharide binding

LGALS9C LGALS9B LGALS9

3.78e-0520663GO:0070492
GeneOntologyBiologicalProcessnegative regulation of natural killer cell degranulation

LGALS9C LGALS9B LGALS9

1.37e-074683GO:0043322
GeneOntologyBiologicalProcessregulation of natural killer cell degranulation

LGALS9C LGALS9B LGALS9

1.90e-068683GO:0043321
GeneOntologyBiologicalProcesscellular response to virus

LGALS9C LGALS9B WDFY4 NLRP3 LGALS9

1.19e-0590685GO:0098586
GeneOntologyBiologicalProcessnegative regulation of CD4-positive, alpha-beta T cell proliferation

LGALS9C LGALS9B LGALS9

1.52e-0515683GO:2000562
GeneOntologyBiologicalProcessnegative regulation of natural killer cell activation

LGALS9C LGALS9B LGALS9

1.52e-0515683GO:0032815
GeneOntologyBiologicalProcessregulation of T-helper 17 type immune response

LGALS9C LGALS9B NLRP3 LGALS9

1.73e-0547684GO:2000316
GeneOntologyBiologicalProcessnegative regulation of leukocyte degranulation

LGALS9C LGALS9B LGALS9

2.25e-0517683GO:0043301
GeneOntologyBiologicalProcessnatural killer cell degranulation

LGALS9C LGALS9B LGALS9

2.70e-0518683GO:0043320
GeneOntologyBiologicalProcessnegative regulation of alpha-beta T cell proliferation

LGALS9C LGALS9B LGALS9

3.20e-0519683GO:0046642
GeneOntologyBiologicalProcesspositive regulation of defense response to bacterium

LGALS9C LGALS9B LGALS9

3.20e-0519683GO:1900426
GeneOntologyBiologicalProcessregulation of T cell chemotaxis

LGALS9C LGALS9B LGALS9

3.75e-0520683GO:0010819
GeneOntologyBiologicalProcessregulation of natural killer cell differentiation

LGALS9C LGALS9B LGALS9

4.37e-0521683GO:0032823
GeneOntologyBiologicalProcessheterophilic cell-cell adhesion via plasma membrane cell adhesion molecules

LGALS9C CADM3 LGALS9B LGALS9

5.56e-0563684GO:0007157
GeneOntologyBiologicalProcessT-helper 17 type immune response

LGALS9C LGALS9B NLRP3 LGALS9

5.91e-0564684GO:0072538
GeneOntologyBiologicalProcessregulation of defense response to bacterium

LGALS9C LGALS9B LGALS9

8.44e-0526683GO:1900424
GeneOntologyBiologicalProcessregulation of CD4-positive, alpha-beta T cell proliferation

LGALS9C LGALS9B LGALS9

1.06e-0428683GO:2000561
GeneOntologyBiologicalProcessCD4-positive, alpha-beta T cell proliferation

LGALS9C LGALS9B LGALS9

1.31e-0430683GO:0035739
GeneOntologyBiologicalProcessregulation of lymphocyte chemotaxis

LGALS9C LGALS9B LGALS9

1.44e-0431683GO:1901623
GeneOntologyBiologicalProcesspositive regulation of regulatory T cell differentiation

LGALS9C LGALS9B LGALS9

1.44e-0431683GO:0045591
GeneOntologyBiologicalProcessnegative regulation of regulated secretory pathway

LGALS9C LGALS9B LGALS9

1.59e-0432683GO:1903306
GeneOntologyBiologicalProcessregulation of oxidoreductase activity

LGALS9C LGALS9B CAV3 LGALS9

1.71e-0484684GO:0051341
GeneOntologyBiologicalProcessT cell chemotaxis

LGALS9C LGALS9B LGALS9

1.74e-0433683GO:0010818
GeneOntologyBiologicalProcesspositive regulation of interleukin-1 production

LGALS9C LGALS9B NLRP3 LGALS9

2.05e-0488684GO:0032732
GeneOntologyBiologicalProcessregulation of T cell differentiation in thymus

LGALS9C LGALS9B LGALS9

2.46e-0437683GO:0033081
GeneOntologyBiologicalProcessnatural killer cell differentiation

LGALS9C LGALS9B LGALS9

2.66e-0438683GO:0001779
GeneOntologyBiologicalProcessnegative regulation of natural killer cell mediated cytotoxicity

LGALS9C LGALS9B LGALS9

3.10e-0440683GO:0045953
GeneOntologyBiologicalProcessnegative regulation of CD4-positive, alpha-beta T cell activation

LGALS9C LGALS9B LGALS9

3.10e-0440683GO:2000515
GeneOntologyBiologicalProcessregulation of CD4-positive, alpha-beta T cell activation

LGALS9C LGALS9B NLRP3 LGALS9

3.34e-04100684GO:2000514
GeneOntologyBiologicalProcessnegative regulation of natural killer cell mediated immunity

LGALS9C LGALS9B LGALS9

3.34e-0441683GO:0002716
GeneOntologyBiologicalProcesspositive regulation of T cell migration

LGALS9C LGALS9B LGALS9

3.34e-0441683GO:2000406
GeneOntologyBiologicalProcessnatural killer cell activation involved in immune response

LGALS9C LGALS9B LGALS9

3.59e-0442683GO:0002323
GeneOntologyBiologicalProcesspositive regulation of macrophage activation

LGALS9C LGALS9B LGALS9

3.59e-0442683GO:0043032
GeneOntologyBiologicalProcessvesicle transport along actin filament

MYO5B MYO5C

3.80e-049682GO:0030050
GeneOntologyBiologicalProcesspositive regulation of SMAD protein signal transduction

LGALS9C LGALS9B LGALS9

3.85e-0443683GO:0060391
GeneOntologyBiologicalProcessnegative regulation of exocytosis

LGALS9C LGALS9B LGALS9

4.40e-0445683GO:0045920
GeneOntologyBiologicalProcesspositive regulation of oxidoreductase activity

LGALS9C LGALS9B LGALS9

4.70e-0446683GO:0051353
GeneOntologyBiologicalProcessnegative regulation of leukocyte mediated cytotoxicity

LGALS9C LGALS9B LGALS9

5.01e-0447683GO:0001911
GeneOntologyBiologicalProcesspositive regulation of interleukin-10 production

LGALS9C LGALS9B LGALS9

5.33e-0448683GO:0032733
GeneOntologyBiologicalProcessnegative regulation of innate immune response

LGALS9C LGALS9B NLRC5 LGALS9

5.49e-04114684GO:0045824
GeneOntologyBiologicalProcesspositive regulation of lymphocyte migration

LGALS9C LGALS9B LGALS9

5.66e-0449683GO:2000403
GeneOntologyBiologicalProcessregulation of regulatory T cell differentiation

LGALS9C LGALS9B LGALS9

5.66e-0449683GO:0045589
GeneOntologyBiologicalProcessactin filament-based transport

MYO5B MYO5C

5.78e-0411682GO:0099515
GeneOntologyBiologicalProcessnegative regulation of type II interferon production

LGALS9C LGALS9B LGALS9

6.37e-0451683GO:0032689
GeneOntologyBiologicalProcessnegative regulation of alpha-beta T cell activation

LGALS9C LGALS9B LGALS9

6.75e-0452683GO:0046636
GeneOntologyBiologicalProcessnegative regulation of cell killing

LGALS9C LGALS9B LGALS9

6.75e-0452683GO:0031342
GeneOntologyBiologicalProcessregulation of alpha-beta T cell proliferation

LGALS9C LGALS9B LGALS9

7.14e-0453683GO:0046640
GeneOntologyBiologicalProcesslymphocyte chemotaxis

LGALS9C LGALS9B LGALS9

7.14e-0453683GO:0048247
GeneOntologyBiologicalProcessnegative regulation of lymphocyte proliferation

LGALS9C LST1 LGALS9B LGALS9

7.53e-04124684GO:0050672
GeneOntologyBiologicalProcessregulatory T cell differentiation

LGALS9C LGALS9B LGALS9

7.54e-0454683GO:0045066
GeneOntologyBiologicalProcessnegative regulation of mononuclear cell proliferation

LGALS9C LST1 LGALS9B LGALS9

7.99e-04126684GO:0032945
GeneOntologyBiologicalProcessregulation of T cell migration

LGALS9C LGALS9B LGALS9

8.38e-0456683GO:2000404
GeneOntologyBiologicalProcessalpha-beta T cell activation

LGALS9C LGALS9B WDFY4 NLRP3 LGALS9

9.17e-04227685GO:0046631
GeneOntologyBiologicalProcessalpha-beta T cell proliferation

LGALS9C LGALS9B LGALS9

9.76e-0459683GO:0046633
GeneOntologyBiologicalProcessnegative regulation of leukocyte proliferation

LGALS9C LST1 LGALS9B LGALS9

1.01e-03134684GO:0070664
GeneOntologyBiologicalProcessregulation of exocytosis

LGALS9C MYO5B LGALS9B SMPD3 LGALS9

1.03e-03233685GO:0017157
GeneOntologyBiologicalProcessregulation of natural killer cell activation

LGALS9C LGALS9B LGALS9

1.08e-0361683GO:0032814
GeneOntologyBiologicalProcessengulfment of apoptotic cell

XKR4 MEGF10

1.09e-0315682GO:0043652
GeneOntologyBiologicalProcessregulation of leukocyte degranulation

LGALS9C LGALS9B LGALS9

1.18e-0363683GO:0043300
GeneOntologyBiologicalProcessregulation of alpha-beta T cell activation

LGALS9C LGALS9B NLRP3 LGALS9

1.21e-03141684GO:0046634
GeneOntologyBiologicalProcesspositive regulation of exosomal secretion

MYO5B SMPD3

1.25e-0316682GO:1903543
GeneOntologyBiologicalProcessregulation of leukocyte chemotaxis

LGALS9C LGALS9B C5AR2 LGALS9

1.28e-03143684GO:0002688
GeneOntologyBiologicalProcesspositive regulation of T cell differentiation

LGALS9C LGALS9B NLRP3 LGALS9

1.31e-03144684GO:0045582
GeneOntologyBiologicalProcesspositive regulation of interleukin-13 production

NLRP3 LGALS9

1.41e-0317682GO:0032736
GeneOntologyBiologicalProcessnegative regulation of response to external stimulus

LGALS9C LGALS9B C5AR2 NLRC5 PLAT NLRP3 LGALS9

1.41e-03509687GO:0032102
GeneOntologyBiologicalProcessregulation of protein tyrosine kinase activity

EFNA1 VPS25 GPRC5B

1.54e-0369683GO:0061097
GeneOntologyBiologicalProcessnegative regulation of response to biotic stimulus

LGALS9C LGALS9B NLRC5 LGALS9

1.56e-03151684GO:0002832
GeneOntologyBiologicalProcessCD4-positive, alpha-beta T cell activation

LGALS9C LGALS9B NLRP3 LGALS9

1.64e-03153684GO:0035710
GeneOntologyBiologicalProcesspositive regulation of non-canonical NF-kappaB signal transduction

SMPD3 NLRP3 LGALS9

1.74e-0372683GO:1901224
GeneOntologyBiologicalProcessregulation of leukocyte migration

LGALS9C LGALS9B C5AR2 SMPD3 LGALS9

1.88e-03267685GO:0002685
GeneOntologyBiologicalProcessregulation of interleukin-10 production

LGALS9C LGALS9B LGALS9

1.88e-0374683GO:0032653
GeneOntologyBiologicalProcessregulation of exosomal secretion

MYO5B SMPD3

1.96e-0320682GO:1903541
GeneOntologyBiologicalProcesspositive regulation of lymphocyte differentiation

LGALS9C LGALS9B NLRP3 LGALS9

2.02e-03162684GO:0045621
GeneOntologyBiologicalProcessregulation of natural killer cell mediated cytotoxicity

LGALS9C LGALS9B LGALS9

2.03e-0376683GO:0042269
GeneOntologyBiologicalProcessinterleukin-10 production

LGALS9C LGALS9B LGALS9

2.11e-0377683GO:0032613
GeneOntologyBiologicalProcessregulation of lymphocyte migration

LGALS9C LGALS9B LGALS9

2.11e-0377683GO:2000401
GeneOntologyBiologicalProcesssphingomyelin metabolic process

SGMS2 SMPD3

2.16e-0321682GO:0006684
GeneOntologyBiologicalProcessregulation of interleukin-1 production

LGALS9C LGALS9B NLRP3 LGALS9

2.16e-03165684GO:0032652
GeneOntologyBiologicalProcesstransforming growth factor beta receptor signaling pathway

LGALS9C LGALS9B CAV3 SPRED3 LGALS9

2.17e-03276685GO:0007179
GeneOntologyBiologicalProcessblastocyst formation

PRAMEF7 PRAMEF8 USPL1

2.19e-0378683GO:0001825
GeneOntologyCellularComponentCul4-RING E3 ubiquitin ligase complex

DCAF4L2 DCAF4 DCAF4L1

2.91e-0438713GO:0080008
MousePhenoincreased T-helper 1 cell number

LGALS9C LGALS9B NLRP3 LGALS9

4.97e-0719494MP:0008086
MousePhenoabnormal T-helper 1 cell number

LGALS9C LGALS9B NLRP3 LGALS9

1.34e-0624494MP:0008085
MousePhenoabnormal T-helper 1 cell morphology

LGALS9C LGALS9B NLRP3 LGALS9

2.31e-0548494MP:0002433
MousePhenoenhanced humoral immune response

LGALS9C LGALS9B LGALS9

2.66e-0517493MP:0020155
MousePhenoincreased T-helper cell number

LGALS9C LGALS9B NLRP3 LGALS9

4.28e-0556494MP:0013763
MousePhenoenlarged lymph nodes

LGALS9C PRAMEF7 PRSS47P LGALS9B OR1E1 PRAMEF8 NLRP3 SPRED3 LGALS9

5.69e-05507499MP:0000702
MousePhenoincreased spleen germinal center size

LGALS9C LGALS9B LGALS9

6.82e-0523493MP:0008483
MousePhenoabnormal lymph node germinal center morphology

LGALS9C LGALS9B LGALS9

6.82e-0523493MP:0008522
MousePhenoabnormal lymph node secondary follicle morphology

LGALS9C LGALS9B LGALS9

8.82e-0525493MP:0002346
MousePhenojoint inflammation

LGALS9C LGALS9B PLAT NLRP3 LGALS9

9.17e-05131495MP:0002933
MousePhenoabnormal lymph node morphology

LGALS9C PRAMEF7 PRSS47P LGALS9B OR1E1 LTBR PRAMEF8 NLRP3 SPRED3 LGALS9

1.06e-046834910MP:0002339
MousePhenoabnormal lymph node size

LGALS9C PRAMEF7 PRSS47P LGALS9B OR1E1 PRAMEF8 NLRP3 SPRED3 LGALS9

1.24e-04561499MP:0000701
MousePhenoabnormal joint physiology

LGALS9C LGALS9B PLAT NLRP3 LGALS9

1.48e-04145495MP:0031169
MousePhenoabnormal Peyer's patch morphology

LGALS9C LGALS9B LTBR LGALS9

2.00e-0483494MP:0000696
MousePhenolymph node hyperplasia

LGALS9C LGALS9B LGALS9

2.05e-0433493MP:0008102
MousePhenoabnormal gut-associated lymphoid tissue morphology

LGALS9C LGALS9B LTBR LGALS9

2.19e-0485494MP:0002378
MousePhenothymus hyperplasia

LGALS9C LGALS9B LGALS9

2.24e-0434493MP:0000708
MousePhenoincreased susceptibility to induced arthritis

LGALS9C LGALS9B LGALS9

2.66e-0436493MP:0003724
MousePhenoabnormal CD4-positive helper T cell morphology

LGALS9C LGALS9B NLRP3 LGALS9

4.08e-04100494MP:0010183
MousePhenoabnormal lymph node B cell domain morphology

LGALS9C LGALS9B LGALS9

4.85e-0444493MP:0002344
MousePhenoabnormal spleen germinal center morphology

LGALS9C LGALS9B LTBR LGALS9

5.27e-04107494MP:0002359
MousePhenoautoimmune arthritis

LGALS9C LGALS9B PLAT LGALS9

5.46e-04108494MP:0002993
MousePhenoabnormal spleen secondary B follicle morphology

LGALS9C LGALS9B LTBR LGALS9

5.66e-04109494MP:0008472
MousePhenoabnormal T-helper cell number

LGALS9C LGALS9B NLRP3 LGALS9

6.70e-04114494MP:0013761
MousePhenoabnormal effector T cell number

LGALS9C LGALS9B LTBR NLRP3 LGALS9

6.98e-04203495MP:0013762
MousePhenoabnormal lymph node cortex morphology

LGALS9C LGALS9B LGALS9

7.07e-0450493MP:0002343
DomainGal-bind_lectin

LGALS9C LGALS9B LGALS9

1.86e-0515663PF00337
DomainGal-bind_lectin

LGALS9C LGALS9B LGALS9

1.86e-0515663SM00908
DomainGALECTIN

LGALS9C LGALS9B LGALS9

1.86e-0515663PS51304
DomainGalectin_CRD

LGALS9C LGALS9B LGALS9

1.86e-0515663IPR001079
DomainGLECT

LGALS9C LGALS9B LGALS9

1.86e-0515663SM00276
DomainMyosin_S1_N

MYO5B MYO5C

1.22e-045662IPR008989
DomainDIL

MYO5B MYO5C

1.83e-046662PF01843
DomainDilute_dom

MYO5B MYO5C

1.83e-046662IPR002710
DomainDILUTE

MYO5B MYO5C

1.83e-046662PS51126
DomainDIL

MYO5B MYO5C

1.83e-046662SM01132
Domain-

PRAMEF7 PXDN LRIG1 NLRC5 PRAMEF8 NLRP3

9.40e-043216663.80.10.10
DomainL_dom-like

PRAMEF7 PXDN LRIG1 NLRC5 PRAMEF8 NLRP3

1.05e-03328666IPR032675
DomainPRAME_family

PRAMEF7 PRAMEF8

2.02e-0319662IPR026271
DomainGPCR_3

TAS1R1 GPRC5B

2.47e-0321662IPR000337
Domain7tm_3

TAS1R1 GPRC5B

2.71e-0322662PF00003
DomainG_PROTEIN_RECEP_F3_2

TAS1R1 GPRC5B

2.71e-0322662PS00980
DomainG_PROTEIN_RECEP_F3_3

TAS1R1 GPRC5B

2.71e-0322662PS00981
DomainG_PROTEIN_RECEP_F3_1

TAS1R1 GPRC5B

2.71e-0322662PS00979
DomainG_PROTEIN_RECEP_F3_4

TAS1R1 GPRC5B

2.71e-0322662PS50259
DomainGPCR_3_C

TAS1R1 GPRC5B

2.71e-0322662IPR017978
DomainNACHT

NLRC5 NLRP3

2.97e-0323662PS50837
DomainNACHT_NTPase

NLRC5 NLRP3

2.97e-0323662IPR007111
Domain-

INPP5A SMPD3

3.78e-03266623.60.10.10
DomainExo_endo_phos

INPP5A SMPD3

3.78e-0326662PF03372
DomainEndo/exonuclease/phosphatase

INPP5A SMPD3

4.08e-0327662IPR005135
Domain-

LGALS9C LGALS9B LGALS9

4.63e-03956632.60.120.200
Domain-

XPO6 HEATR5A WDFY4 MED12

7.88e-032226641.25.10.10
DomainMyosin_head_motor_dom

MYO5B MYO5C

7.97e-0338662IPR001609
DomainMYOSIN_MOTOR

MYO5B MYO5C

7.97e-0338662PS51456
DomainMyosin_head

MYO5B MYO5C

7.97e-0338662PF00063
Pubmed

Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation.

LGALS9C LGALS9B NLRP3 LGALS9

1.89e-11474433963043
Pubmed

Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis.

LGALS9C LGALS9B LGALS9

9.25e-09374329458010
Pubmed

Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.

LGALS9C LGALS9B LGALS9

9.25e-09374319776007
Pubmed

Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9.

LGALS9C LGALS9B LGALS9

9.25e-09374326582205
Pubmed

Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.

LGALS9C LGALS9B LGALS9

9.25e-0937439153289
Pubmed

Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis.

LGALS9C LGALS9B LGALS9

9.25e-09374333316546
Pubmed

Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice.

LGALS9C LGALS9B LGALS9

9.25e-09374318974023
Pubmed

Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin.

LGALS9C LGALS9B LGALS9

9.25e-0937439038233
Pubmed

Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion.

LGALS9C LGALS9B LGALS9

9.25e-09374323144904
Pubmed

Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings.

LGALS9C LGALS9B LGALS9

9.25e-09374329651447
Pubmed

Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.

LGALS9C LGALS9B LGALS9

9.25e-09374328704475
Pubmed

The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity.

LGALS9C LGALS9B LGALS9

9.25e-09374321146220
Pubmed

Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.

LGALS9C LGALS9B LGALS9

9.25e-09374323836896
Pubmed

Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes.

LGALS9C LGALS9B LGALS9

9.25e-0937437890611
Pubmed

Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.

LGALS9C LGALS9B LGALS9

9.25e-09374322341088
Pubmed

Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9.

LGALS9C LGALS9B LGALS9

9.25e-09374328990062
Pubmed

Galectin-9 Is a Novel Regulator of Epithelial Restitution.

LGALS9C LGALS9B LGALS9

9.25e-09374332380082
Pubmed

Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.

LGALS9C LGALS9B LGALS9

9.25e-09374323667648
Pubmed

Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.

LGALS9C LGALS9B LGALS9

9.25e-09374318579572
Pubmed

Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.

LGALS9C LGALS9B LGALS9

9.25e-09374328877989
Pubmed

Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.

LGALS9C LGALS9B LGALS9

9.25e-09374319800850
Pubmed

The effect of Toxoplasma gondii infection on galectin-9 expression in decidual macrophages contributing to dysfunction of decidual NK cells during pregnancy.

LGALS9C LGALS9B LGALS9

9.25e-09374338987795
Pubmed

Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.

LGALS9C LGALS9B LGALS9

9.25e-09374316990264
Pubmed

Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.

LGALS9C LGALS9B LGALS9

9.25e-09374318005988
Pubmed

Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.

LGALS9C LGALS9B LGALS9

9.25e-09374323585851
Pubmed

Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.

LGALS9C LGALS9B LGALS9

9.25e-09374324477688
Pubmed

A unique role for galectin-9 in angiogenesis and inflammatory arthritis.

LGALS9C LGALS9B LGALS9

9.25e-09374329433546
Pubmed

Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.

LGALS9C LGALS9B LGALS9

9.25e-09374337105392
Pubmed

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson's disease.

LGALS9C LGALS9B LGALS9

9.25e-09374336479526
Pubmed

Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.

LGALS9C LGALS9B LGALS9

9.25e-09374323242525
Pubmed

Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.

LGALS9C LGALS9B LGALS9

9.25e-09374319851072
Pubmed

The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.

LGALS9C LGALS9B LGALS9

9.25e-09374333923930
Pubmed

Alarmin function of galectin-9 in murine respiratory tularemia.

LGALS9C LGALS9B LGALS9

9.25e-09374325898318
Pubmed

Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells.

LGALS9C LGALS9B LGALS9

9.25e-09374331937306
Pubmed

Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine.

LGALS9C LGALS9B LGALS9

9.25e-09374321426359
Pubmed

Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases.

LGALS9C LGALS9B LGALS9

9.25e-09374331969388
Pubmed

Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis.

LGALS9C LGALS9B LGALS9

9.25e-09374318282810
Pubmed

Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.

LGALS9C LGALS9B LGALS9

9.25e-09374335241678
Pubmed

Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations.

LGALS9C LGALS9B LGALS9

9.25e-09374324083426
Pubmed

Galectin-9 in synergy with NF-κB inhibition restores immune regulatory capability in dendritic cells of subjects with food allergy.

LGALS9C LGALS9B LGALS9

9.25e-09374337279535
Pubmed

The protective function of galectin-9 in liver ischemia and reperfusion injury in mice.

LGALS9C LGALS9B LGALS9

9.25e-09374325931247
Pubmed

Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.

LGALS9C LGALS9B LGALS9

9.25e-09374322627368
Pubmed

Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in mice.

LGALS9C LGALS9B LGALS9

9.25e-09374333153471
Pubmed

T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.

LGALS9C LGALS9B LGALS9

9.25e-09374322052881
Pubmed

Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes.

LGALS9C LGALS9B LGALS9

9.25e-09374317560833
Pubmed

Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner.

LGALS9C LGALS9B LGALS9

9.25e-09374335643073
Pubmed

Galectin-9 functionally impairs natural killer cells in humans and mice.

LGALS9C LGALS9B LGALS9

9.25e-09374323408620
Pubmed

SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9.

LGALS9C LGALS9B LGALS9

3.69e-08474338686388
Pubmed

Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.

LGALS9C LGALS9B LGALS9

3.69e-08474322677125
Pubmed

Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.

LGALS9C LGALS9B LGALS9

3.69e-08474319234217
Pubmed

Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis.

LGALS9C LGALS9B LGALS9

3.69e-08474335715604
Pubmed

Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

LGALS9C LGALS9B LGALS9

3.69e-08474319017954
Pubmed

Galectin-9: A novel promoter of atherosclerosis progression.

LGALS9C LGALS9B LGALS9

3.69e-08474336459823
Pubmed

Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts.

LGALS9C LGALS9B LGALS9

3.69e-08474333107565
Pubmed

Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models.

LGALS9C LGALS9B LGALS9

3.69e-08474329611821
Pubmed

Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway.

LGALS9C LGALS9B LGALS9

3.69e-08474330763585
Pubmed

Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2.

LGALS9C LGALS9B LGALS9

3.69e-08474333727589
Pubmed

Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.

LGALS9C LGALS9B LGALS9

3.69e-08474319362679
Pubmed

The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy.

LGALS9C LGALS9B LGALS9

3.69e-08474325578313
Pubmed

Intestinal Lamina Propria CD4+ T Cells Promote Bactericidal Activity of Macrophages via Galectin-9 and Tim-3 Interaction during Salmonella enterica Serovar Typhimurium Infection.

LGALS9C LGALS9B LGALS9

3.69e-08474329844236
Pubmed

Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.

LGALS9C LGALS9B LGALS9

3.69e-08474320463811
Pubmed

Lumenal Galectin-9-Lamp2 interaction regulates lysosome and autophagy to prevent pathogenesis in the intestine and pancreas.

LGALS9C LGALS9B LGALS9

3.69e-08474332855403
Pubmed

Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain.

LGALS9C LGALS9B LGALS9

3.69e-08474323657851
Pubmed

[Expression and significance of galectin-3 and galectin-9 in mice nasal mucosa with allergic rhinitis].

LGALS9C LGALS9B LGALS9

3.69e-08474318826117
Pubmed

The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.

LGALS9C LGALS9B LGALS9

3.69e-08474324333756
Pubmed

The expression of Galectin-9 correlates with mTOR and AMPK in murine colony-forming erythroid progenitors.

LGALS9C LGALS9B LGALS9

3.69e-08474338853593
Pubmed

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies.

LGALS9C LGALS9B LGALS9

3.69e-08474324958847
Pubmed

Galectin-9 binds IgM-BCR to regulate B cell signaling.

LGALS9C LGALS9B LGALS9

3.69e-08474330120235
Pubmed

[Expression of Galectin-9 and Tim-3 in lungs of mice with asthma].

LGALS9C LGALS9B LGALS9

3.69e-08474321575348
Pubmed

Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.

LGALS9C LGALS9B LGALS9

3.69e-08474318346632
Pubmed

Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge.

LGALS9C LGALS9B LGALS9

3.69e-08474311839756
Pubmed

Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice.

LGALS9C LGALS9B LGALS9

3.69e-08474319670381
Pubmed

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

LGALS9C LGALS9B LGALS9

3.69e-08474325450716
Pubmed

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.

LGALS9C LGALS9B LGALS9

3.69e-08474316286920
Pubmed

Galectin-9 regulates the threshold of B cell activation and autoimmunity.

LGALS9C LGALS9B LGALS9

3.69e-08474334369876
Pubmed

Targeting the CD146/Galectin-9 axis protects the integrity of the blood-brain barrier in experimental cerebral malaria.

LGALS9C LGALS9B LGALS9

3.69e-08474333203936
Pubmed

Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency.

LGALS9C LGALS9B LGALS9

3.69e-08474322021615
Pubmed

Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling.

LGALS9C LGALS9B LGALS9

9.22e-08574329242193
Pubmed

Tim-3 signaling in peripheral NK cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss.

LGALS9C LGALS9B LGALS9

9.22e-08574328951537
Pubmed

Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner.

LGALS9C LGALS9B LGALS9

9.22e-08574334847625
Pubmed

Tim-2 up-regulation and galectin-9-Tim-3 pathway activation in Th2-biased response in Schistosoma japonicum infection in mice.

LGALS9C LGALS9B LGALS9

9.22e-08574322469568
Pubmed

Astrocyte galectin-9 potentiates microglial TNF secretion.

LGALS9C LGALS9B LGALS9

9.22e-08574325158758
Pubmed

C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells.

LGALS9C LGALS9B LGALS9

9.22e-08574319782405
Pubmed

Embryonic implantation in galectin 1/galectin 3 double mutant mice.

LGALS9C LGALS9B LGALS9

9.22e-0857439566950
Pubmed

Feto-maternal immune regulation by TIM-3/galectin-9 pathway and PD-1 molecule in mice at day 14.5 of pregnancy.

LGALS9C LGALS9B LGALS9

9.22e-08574326278059
Pubmed

Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens.

LGALS9C LGALS9B LGALS9

9.22e-08574337352334
Pubmed

Serial transplantation unmasks galectin-9 contribution to tumor immune escape in the MB49 murine model.

LGALS9C LGALS9B LGALS9

9.22e-08574333664349
Pubmed

The glucose transporter 2 regulates CD8+ T cell function via environment sensing.

LGALS9C LGALS9B LGALS9

9.22e-08574337884694
Pubmed

Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.

LGALS9C LGALS9B LGALS9

9.22e-08574321385853
Pubmed

Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.

LGALS9C LGALS9B LGALS9

1.84e-07674328394331
Pubmed

Tim3 binding to galectin-9 stimulates antimicrobial immunity.

LGALS9C LGALS9B LGALS9

1.84e-07674320937702
Pubmed

Galectins in mouse embryogenesis.

LGALS9C LGALS9B LGALS9

1.84e-0767438674632
Pubmed

Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease.

LGALS9C LGALS9B LGALS9

1.84e-07674323296703
Pubmed

Role of galectin-1 in the developing mouse olfactory system.

LGALS9C LGALS9B LGALS9

3.22e-0777438873770
Pubmed

Mammalian galectins bind galactoseβ1-4fucose disaccharide, a unique structural component of protostomial N-type glycoproteins.

LGALS9C LGALS9B LGALS9

5.14e-07874323751344
Pubmed

Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer.

LGALS9C LGALS9B LGALS9

5.14e-07874331661141
Pubmed

Mesenchymal stem cells protect against sepsis-associated acute kidney injury by inducing Gal-9/Tim-3 to remodel immune homeostasis.

LGALS9C LGALS9B LGALS9

5.14e-07874336883358
Pubmed

Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry.

LGALS9C LGALS9B LGALS9

7.70e-07974321670307
Pubmed

Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells.

LGALS9C LGALS9B LGALS9

7.70e-07974325065622
Pubmed

Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation.

LGALS9C LGALS9B LGALS9

2.01e-061274323817958
GeneFamilyGalectins

LGALS9C LGALS9B LGALS9

9.96e-0615523629
GeneFamilyMyosins, class V

MYO5B MYO5C

2.43e-0535221100
GeneFamilyPRAME family

PRAMEF7 PRAMEF8

2.15e-0324522686
GeneFamilyNLR family

NLRC5 NLRP3

2.33e-0325522666
GeneFamilyCyclins|Mediator complex

MED13L MED12

4.05e-03335221061
GeneFamilyOlfactory receptors, family 1

OR1E1 OR1P1

5.90e-0340522147
GeneFamilyWD repeat domain containing

DCAF4L2 WDFY4 DCAF4 DCAF4L1

6.77e-03262524362
CoexpressionMIKKELSEN_ES_ICP_WITH_H3K4ME3

PRAMEF7 DCAF4L2 LRRN4CL TPP1 MRGPRE ZFYVE26 PLAT PRAMEF8 DCAF4 DCAF4L1 MEGF10 SPRED3

2.19e-068077312MM855
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

LGALS9C WBP1 PXDN INPP5A MYO5C

7.73e-061637456c4d4c55fc8a731acca13c1ba7287f238a9d81e0
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 LRRN4CL PEDS1 DENND1C SPRN

9.21e-0616974515a9183c838cc6384d7f5dfeae3d30602964c9b3
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

LGALS9C WBP1 PXDN INPP5A MYO5C

9.47e-06170745c1f7f1bb8865e954bb499963d82bb51923d5d8d6
ToppCellfacs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LST1 C5AR2 PEDS1 TM4SF19 NLRP3

9.75e-0617174526755e43d94e934106fc19ab929e4d34c17d6cba
ToppCell10x5'-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue

SMPD3 WDFY4 SLC4A3 MEGF10 LGALS9

1.09e-051757451c48eec300d5a6d4a810947b995af3b8c0a5a601
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CADM3 SGMS2 LRRN4CL SMPD3 GPRC5B

1.25e-05180745c4068fe47408cfd899131a85fa4b7e5908926f94
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

LST1 LTBR WDFY4 NLRP3 LGALS9

1.25e-051807452bc3fd2e4c249bf236340c5f0483747faa5c04ec
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

LST1 LTBR WDFY4 NLRP3 LGALS9

1.28e-051817451b4eb044825ede6361928442524b1988c8ef58b3
ToppCell11.5-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class

LST1 DENND1C WDFY4 NLRP3 LGALS9

1.28e-05181745193ee02f547a218b2fc13e1174ea4cff4f8a3450
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

LST1 LTBR WDFY4 NLRP3 LGALS9

1.28e-051817458d7ebbedc373d55e29da02ac2728b4f4118038f2
ToppCelldroplet-Limb_Muscle-nan-3m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM201 EFNA1 TMEM44 NLRC5 DCAF4

1.58e-0518974516a4c92dd7a0d60f3691bd3130a091a9a54730f1
ToppCellPCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LST1 TMEM144 C5AR2 WDFY4 NLRP3

1.62e-05190745081b7bc07b6e5685e8a91b9ae6c1141623723700
ToppCellMonocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis

LST1 LTBR WDFY4 SLC4A3 NLRP3

1.93e-051977453388c104af4c6a05988e102627e0c5e34d9dcc45
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LST1 TMEM144 LTBR NLRP3 LGALS9

2.02e-051997457dde5c02fcae64cd2d68f607500f2a46b97851fd
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-myeloid|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LST1 SGMS2 C5AR2 LTBR LGALS9

2.02e-051997450f3ce61bbae69f7e333ed8dacf7257645624e163
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LST1 TMEM144 LTBR NLRP3 LGALS9

2.02e-0519974584879280851380e5bfe6bd48b6bbf57aedf6e003
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal|GW23 / Sample Type, Dataset, Time_group, and Cell type.

LST1 TMEM144 TPP1 LTBR LGALS9

2.07e-052007450eccf41edefc3b8b5d0316f57d5ba572949aec2b
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type.

LST1 TMEM144 TPP1 LTBR LGALS9

2.07e-0520074501d707c4f8ee0daac635b7260937b1baebc6fc23
ToppCellCOVID-19-COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease, condition lineage and cell class

LST1 SGMS2 LTBR WDFY4 LGALS9

2.07e-05200745ac9d7927863348a752444d2e80269a5eead943b7
ToppCellStriatum-Hematopoietic-MACROPHAGE|Striatum / BrainAtlas - Mouse McCarroll V32

C5AR2 NLRC5 DENND1C WDFY4

4.49e-0511874454930a3faa055bda4a707b93d790b2ac5a360211
ToppCellStriatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Striatum / BrainAtlas - Mouse McCarroll V32

C5AR2 NLRC5 DENND1C WDFY4

4.49e-0511874418f9c1759df9504962612ec741638ed330c33222
ToppCellStriatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Striatum / BrainAtlas - Mouse McCarroll V32

C5AR2 NLRC5 DENND1C WDFY4

4.49e-0511874497db1193ecc885f63840663ab969468ce21cba74
ToppCellStriatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Striatum / BrainAtlas - Mouse McCarroll V32

C5AR2 NLRC5 DENND1C WDFY4

4.49e-051187440c2fe46dd66e0c9cdf8c2eb66874aca79592248a
ToppCellStriatum-Hematopoietic-MACROPHAGE-MP1(C1qb)|Striatum / BrainAtlas - Mouse McCarroll V32

C5AR2 NLRC5 DENND1C WDFY4

4.49e-051187443f8d11e09a7660af9eca5249ad698d9b638d39dd
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

C5AR2 XKR4 SLC14A2 LGALS9

7.58e-051357449f9d0787a2e99207a9caa88a85565189ab8b940a
ToppCellHippocampus-Hematopoietic|Hippocampus / BrainAtlas - Mouse McCarroll V32

C5AR2 DENND1C WDFY4 NLRP3

1.17e-0415174481b2189afd72658f7e2539b856ba79cd49340215
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

C5AR2 XKR4 SLC14A2 LGALS9

1.17e-041517442f9b3e14c2fa6e2b1976ca6ab2031b63bf5e3e64
ToppCellStriatum-Hematopoietic|Striatum / BrainAtlas - Mouse McCarroll V32

C5AR2 NLRC5 DENND1C WDFY4

1.29e-0415574412301d823338bf829475905c66c5f08f7159d29f
ToppCellfacs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 SGMS2 C5AR2 NLRP3

1.32e-04156744f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655
ToppCellfacs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 SGMS2 C5AR2 NLRP3

1.32e-04156744da4f35353a84d919e683554932f110e29568df33
ToppCellfacs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 SGMS2 C5AR2 NLRP3

1.32e-04156744f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1
ToppCellPBMC-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters

EFHC2 CADM3 PXDN DCAF4L1

1.39e-041587445fefab4831687cd8dd45f5cc84f681398069c3be
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

PXDN INPP5A C5AR2 MYO5C

1.43e-041597441472536eea61d4f13033efe42f128bae1614fa74
ToppCellfacs-Lung-nan-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 SGMS2 C5AR2 NLRP3

1.43e-04159744836c4b5f9a714ffb5a449087ebefdbb37dd3a2a9
ToppCellfacs-Lung-nan-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 SGMS2 C5AR2 NLRP3

1.43e-04159744a6742ba2216427409173aec4e05a537d7fde226c
ToppCellSubstantia_nigra-Hematopoietic|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

LST1 C5AR2 DENND1C WDFY4

1.46e-0416074419d71d02f06f34eff37d268a78e5eed34da4ca44
ToppCellfrontal_cortex-Non-neuronal-macrophage-Macrophage-Microglia_Siglech|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

C5AR2 DENND1C NLRP3 LGALS9

1.46e-04160744c3f2f362e5d0602bb997e8367b4c9a8fe88e4ea8
ToppCellfacs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 CADM3 LTBR NLRP3

1.50e-0416174445591addc765760db6029ac19e80573373d1d917
ToppCellfacs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 CADM3 LTBR NLRP3

1.50e-041617448741b91a62c9a8ce377ef6533d323b65beb93c63
ToppCellfacs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 CADM3 LTBR NLRP3

1.50e-041617449cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CADM3 C1orf220 XKR4 MEGF10

1.53e-04162744d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae
ToppCellfacs-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LST1 SGMS2 C5AR2 NLRP3

1.53e-04162744ad974426039f4952c59d27167eac24dc6ce63f5e
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CADM3 C1orf220 XKR4 MEGF10

1.53e-041627445bbd7130d4dad9035e73a439dda568195c136f31
ToppCelldroplet-Lung-21m-Hematologic-myeloid-neutrophil|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LST1 SGMS2 C5AR2 NLRP3

1.53e-04162744f24eb596653180040bfdefad9c246fc42cbfaac8
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CADM3 C1orf220 XKR4 MEGF10

1.53e-04162744eed223e61c8162a2fe004ab4e09de5e037be7553
ToppCellfacs-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LST1 SGMS2 C5AR2 NLRP3

1.53e-041627444e7e565091bce227d794a36af2e5dfc4a791efad
ToppCelldroplet-Lung-21m-Hematologic-myeloid-neutrophil-neutrophil|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LST1 SGMS2 C5AR2 NLRP3

1.53e-041627441a953e165b7e469815294728350ec13d27c9bd9d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CADM3 C1orf220 XKR4 MEGF10

1.53e-04162744e35ddce830e20ebeac1a2c405293fc4a5323dd4a
ToppCellfrontal_cortex-Non-neuronal-macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

C5AR2 DENND1C NLRP3 LGALS9

1.57e-04163744b89f586b444f90047c8ce407f53847fd1ee7cca3
ToppCellfrontal_cortex-Non-neuronal-macrophage-Macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

C5AR2 DENND1C NLRP3 LGALS9

1.57e-04163744cbe9b4c4b2e42e9f92a57ed66758af93434db5bb
ToppCellPBMC-Severe-Myeloid-cDC-cDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

WBP1 TMEM201 LTBR NLRP3

1.57e-04163744ec8336b68c8369e27d507c04c827be07bb48a7f6
ToppCellfacs-Marrow-KLS-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CADM3 LRIG1 MYO5B SPRED3

1.57e-04163744b83a35c4426d66b5734a98fa6c72b345fe462030
ToppCellfacs-Marrow-KLS-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CADM3 LRIG1 MYO5B SPRED3

1.57e-04163744c20ca9b6b4170ebcb0e66eef3e5d8ebff22b1a91
ToppCellfacs-Lung-Endomucin-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 C5AR2 ZFYVE26 NLRP3

1.68e-041667445126d8f02314717eed341d867856fd4fe16c5118
ToppCellThalamus-Hematopoietic|Thalamus / BrainAtlas - Mouse McCarroll V32

LST1 C5AR2 WDFY4 NLRP3

1.68e-0416674476d60ac7ac5d1eaf530f0c741d9c48e0bd58396b
ToppCellfacs-Lung-Endomucin-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 C5AR2 ZFYVE26 NLRP3

1.68e-041667443037bdca38c3a65eacfa644219cc43c54e303749
ToppCellPND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LRRN4CL MYO5B SMPD3 XKR4

1.72e-04167744c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2
ToppCellPND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LRRN4CL MYO5B SMPD3 XKR4

1.72e-04167744351f8de1fbdf742ac74f9099b254d515ab539bb2
ToppCelldroplet-Heart-4Chambers-21m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 DENND1C WDFY4 NLRP3

1.76e-041687448ff4666fdda562913060b1cfa2dfab34e0606794
ToppCell3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLAT PCDHA1 XKR4 MEGF10

1.76e-04168744af82e07d1eec51fc6530155f37addbce6221885d
ToppCellhealthy_donor-Myeloid-Monocytic-Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass

LST1 XPO6 C5AR2 SLC45A4

1.76e-0416874404259f5a9b067cd1b5619e34591e4b2fccc18535
ToppCellfacs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LST1 C5AR2 PEDS1 NLRP3

1.80e-041697448180aeda13c511260d0542a94156059d558848a7
ToppCelldroplet-Heart-4Chambers-21m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 DENND1C WDFY4 NLRP3

1.80e-041697443296305dc4fa40c466dab56aab4eac302ae3d7f7
ToppCelldroplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LST1 SGMS2 C5AR2 NLRP3

1.84e-04170744dbd6c9c7be824a1ff1b31af791064127cafbd194
ToppCell10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-ELP|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

LST1 RNF150 MED13L MYO5C

1.84e-04170744a50e558d0b38100ccbdccb90647fe93e85bffd86
ToppCell10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue

SMPD3 WDFY4 SLC4A3 MEGF10

1.84e-0417074459cb1262ff319349d42b11afbec2a9035b7b79f2
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-5|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

C1orf220 LRIG1 HEATR5A WDFY4

1.88e-0417174423b3120706bb9c20b9214fe3760c6d7a84f1e749
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

PXDN INPP5A C5AR2 MYO5C

1.97e-041737447e2149205e119cec4f5099c83c85d1e13470137a
ToppCellPND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass

PXDN LRRN4CL TMEM44 LGALS9

2.01e-04174744b4f3f5334803e5903bc496decf923f2e44f7fa3c
ToppCellwk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

NLRC5 HEATR5A NALF2 KCNH5

2.15e-0417774415a5c96ea840376e54933ebe7a8334a11d9ce411
ToppCell15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class

EFHC2 SGMS2 MYO5B MYO5C

2.20e-04178744d8e0a696bdd6af6422d72af0413f9dbd6bc02afa
ToppCellControl-Myeloid-Monocytes,_Macrophages|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LST1 C5AR2 WDFY4 NLRP3

2.24e-04179744a79a244bf8ecc333d034b2eb2de554d3310ca6de
ToppCellControl-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LST1 C5AR2 WDFY4 NLRP3

2.24e-04179744c4ff8b191ed0f6dc2dd784869f6f2c62e170a7db
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SGMS2 MYO5B HEATR5A MYO5C

2.24e-0417974404ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CADM3 TAS1R1 NALF2 KCNH5

2.24e-04179744b8ca29aebd25ebac441bebd769bbf98c536d3166
ToppCell3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CADM3 PLAT XKR4 MEGF10

2.34e-04181744a436e7e4c36403257ea90160a58ca0d6d7c0cdfc
ToppCelldroplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRIG1 PLAT GPRC5B SLC45A4

2.34e-04181744136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell11.5-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class

EFHC2 LST1 NLRC5 LGALS9

2.34e-04181744727344d7b2953568b7b3463398c7d56878cf2c2b
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

LST1 TPP1 TAS1R1 WDFY4

2.34e-04181744c8286a7ac8e3cc5aa7e92b043a08435294ea686f
ToppCellControl-Myeloid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LST1 C5AR2 WDFY4 NLRP3

2.34e-0418174425170e5285996cc80337d5f86a0255569861ae77
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LST1 TPP1 C5AR2 LGALS9

2.44e-04183744103c4c4595d8daa677679fd2fa1e99cd398e56dd
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-cDC1|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LST1 WDFY4 NLRP3 LGALS9

2.44e-04183744661bfc8f5f683b0f4c12bdd359e67c513b181678
ToppCell3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue

LST1 LTBR SLC4A3 LGALS9

2.44e-04183744f482e4fe011fa450a475034b1e25587233855bdb
ToppCellCOVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class

LST1 LTBR WDFY4 LGALS9

2.49e-04184744ad6e910eaebe841a68a5f2f329d43dafc5db158a
ToppCellPBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

LST1 LTBR WDFY4 LGALS9

2.49e-041847449d678b24532b7763f2e73f7ccb496259977c5204
ToppCellPBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

LST1 LTBR WDFY4 LGALS9

2.49e-04184744383374ad17bd322b8d703a22e475d34ca7b2e6b6
ToppCellPBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)

LST1 LTBR WDFY4 LGALS9

2.49e-041847445535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RNF150 PXDN LRIG1 PLAT

2.49e-04184744e7b9c69fc77040c5191ad8089697051e2589c30e
ToppCelldroplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFNA1 LRIG1 PLAT SMPD3

2.54e-04185744eeb6f55a6f79adf80247baa2c4b0df44553557ad
ToppCell3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EFNA1 GPRC5B MYO5C SLC45A4

2.54e-04185744602536a3308a848f106adcb0a83530997440c8f4
ToppCell10x5'-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue

LST1 LTBR SLC4A3 LGALS9

2.54e-04185744f78be85dd6e443abb7af20f98ff351c1131ece4d
ToppCellfacs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CADM3 LRRN4CL SMPD3 GPRC5B

2.65e-04187744fa8f221b4c2df61eadaa9c77e4cf45848b00330b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGMS2 MYO5B XKR4 MYO5C

2.65e-0418774487b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

EFNA1 XKR4 MYO5C SLC45A4

2.65e-041877444ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCellmetastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass

CADM3 RNF150 XKR4 GPRC5B

2.65e-04187744e04fb35f2f5b120659d06b5ae427ab1ec56d5c36
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGMS2 MYO5B XKR4 MYO5C

2.65e-0418774442a1267bfc27b4460b8409ada580a87c4385841c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGMS2 MYO5B XKR4 MYO5C

2.65e-0418774464afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCellFetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LST1 C5AR2 NLRP3 SLC45A4

2.65e-0418774439b99f46b723f7f3c44880d7fe8642cbad558b8a
ToppCellP03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

EFNA1 TMEM44 PLAT SLC45A4

2.65e-0418774466ebe1788d51b3e17bec6cdb219f709756b4e530
ToppCellfacs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM144 MYO5B CAV3 SLC4A3

2.70e-041887444db566f3f708e66730aa9e16f4d73d91dc534177
Diseasesleep measurement

PXDN XKR4 SLC14A2 TRAV24

2.29e-04135654EFO_0004870
Diseaselongitudinal BMI measurement, response to amisulpride

SLC14A2 KCNH5

1.87e-0329652EFO_0005937, EFO_0010718
Disease1,5 anhydroglucitol measurement

EFNA1 PCDHA1

1.87e-0329652EFO_0008009
Diseasebirth weight

LRIG1 HEATR5A SMPD3 GPRC5B SLC45A4

1.87e-03399655EFO_0004344
DiseaseDrug habituation

XPO6 XKR4 MYO5C

2.11e-03115653C0013170
DiseaseSubstance-Related Disorders

XPO6 XKR4 MYO5C

2.11e-03115653C0236969
DiseaseDrug abuse

XPO6 XKR4 MYO5C

2.11e-03115653C0013146
DiseaseDrug Use Disorders

XPO6 XKR4 MYO5C

2.11e-03115653C0013222
DiseaseDrug Dependence

XPO6 XKR4 MYO5C

2.11e-03115653C1510472
DiseaseSubstance Dependence

XPO6 XKR4 MYO5C

2.11e-03115653C0038580
DiseaseSubstance Use Disorders

XPO6 XKR4 MYO5C

2.11e-03115653C0038586
DiseaseOrganic Mental Disorders, Substance-Induced

XPO6 XKR4 MYO5C

2.11e-03115653C0029231
DiseasePrescription Drug Abuse

XPO6 XKR4 MYO5C

2.11e-03115653C4316881
DiseaseSubstance abuse problem

XPO6 XKR4 MYO5C

2.17e-03116653C0740858

Protein segments in the cluster

PeptideGeneStartEntry
CWASLNHLDSHILLC

DCAF4

231

Q8WV16
HLFTCIQLGCIALLW

SLC4A3

1156

P48751
HACALAWLDTQDRCL

ALDH16A1

26

Q8IZ83
TWFLHRCSCILNLEE

BAALC-AS2

51

P0C853
ASLLLLLLLFACCWA

CADM3

6

Q8N126
TQSCLCILSHLPWFE

DENND1C

91

Q8IV53
CVLHCLSPCLAWSFL

ABHD8

296

Q96I13
NSCLSFICLLLCHWI

MEGF10

6

Q96KG7
LALLSCAALVWHFCL

LRRN4CL

206

Q8ND94
CLSHDQRWLLASCTD

MED13L

1831

Q71F56
HISSDSFLCDCQLKW

LRIG1

436

Q96JA1
SFSVWILCEAHCLKV

LGALS9C

306

Q6DKI2
SFSVWILCEAHCLKV

LGALS9B

306

Q3B8N2
FSVWILCEAHCLKVA

LGALS9

306

O00182
LLVCVFGLVAHWLAC

KCNH5

351

Q8NCM2
CWASLNQLDSHVLLC

DCAF4L1

131

Q3SXM0
CWASLNHLDSHLLLC

DCAF4L2

131

Q8NA75
HGKILCFFCLWDDSV

EFHC2

226

Q5JST6
WCIADCAFDLVNIHL

INPP5A

171

Q14642
EWCSVILCFSLIAHN

PEDS1

46

A5PLL7
LCCPSALVWHYSLTD

MED12

371

Q93074
LFFTVLLADHLWLCA

NALF2

51

O75949
TCVCALTWALCLLLH

MRGPRE

141

Q86SM8
SCLSALHCVSWALIF

SMPD3

11

Q9NY59
LAVCLLCWTPFHLAS

NPBWR2

266

P48146
AVSACWTLAELHISL

NLRC5

921

Q86WI3
CQWSAECSIHLELIA

PCDHA1

96

Q9Y5I3
VLFALCFSCLLSQAW

GPRC5B

131

Q9NZH0
SISVRLAAAWCLHCI

HEATR5A

456

Q86XA9
TWLLHLAVADLLCCL

C5AR2

71

Q9P296
AWILCIFQLFHQCLS

CPLANE1

631

Q9H799
LCCSLAAADRHTVFW

EFNA1

11

P20827
LLWGFLFACISFCHI

CAV3

86

P56539
SCTLHWSFLLSQVRC

ENGASE

646

Q8NFI3
SLLQFWCCLSRLSFH

C1orf220

106

Q5T0J3
DCLLSESDLKHLSWC

PRAMEF8

301

Q5VWM4
QWLHLLSLSVVCCIF

PKD1L1

2166

Q8TDX9
LLAVVLLSACLCWLH

LST1

21

O00453
CLALVALSWVLTTFH

OR1E1

141

P30953
SLHRCAFLVTACWTL

OR1P1

151

Q8NH06
TWLLSFCFVHLLCLD

RNF150

16

Q9ULK6
CNLTSHCCWDLSTLL

NLRP3

951

Q96P20
ILETHLTWLCICSGF

PIGF

36

Q07326
IDSCWLVSTTHCFLN

PRSS47P

111

A8MTI9
YHLICWLLSAAGIIC

SGMS2

251

Q8NHU3
LCLCHLLTWFSVIAE

SLC45A4

511

Q5BKX6
DCLLSESDLKHLSWC

PRAMEF7

301

Q5VXH5
CLFTCVLQLSHSWSV

WNT8B

11

Q93098
NAYALCWLDCILSAL

USPL1

231

Q5W0Q7
CWLDCILSALVHSEE

USPL1

236

Q5W0Q7
AAWCSLVLSFCRLHK

VPS25

31

Q9BRG1
LISSCWILSAAHCFQ

PLAT

346

P00750
LILWFHLDCVSSILN

TRAV24

11

A0A0B4J272
LQLLISCCWAFACHS

TAS1R1

11

Q7RTX1
TCFCCLITWLEGHSL

NAA35

111

Q5VZE5
WSHCSLSEALLDLSD

THAP9

696

Q9H5L6
ATCWALLLAAAFLCD

SPRN

6

Q5BIV9
AIATCCWFIANHSLS

TMEM144

276

Q7Z5S9
CLWCAESLLYHCLSD

SPRED3

331

Q2MJR0
SNTLHCDCEILWLAD

PXDN

191

Q92626
SQDCTCILWDLDHLT

WDFY4

3001

Q6ZS81
DSWVADALCLLCLSH

TTC41P

601

Q6P2S7
ASCSFCIWLLQSLIH

XKR4

246

Q5GH76
ASSCWIAAHALLLYL

TMEM44

36

Q2T9K0
FCTCLWALLLGLHLA

TMEM201

326

Q5SNT2
FCAAWALECTHCELL

LTBR

131

P36941
LCWVTLCLLAAGHSE

TRBV17

6

A0A087X0K7
CSLALECLAHLFSWI

XPO6

246

Q96QU8
WQTHLLALICALFCA

SLC14A2

366

Q15849
SCLLVLLGWTHCQSL

ZFYVE26

366

Q68DK2
LLWTVLILFSCCCAF

WBP1

61

Q96G27
VWHVSLFSALLCISL

TM4SF19

171

Q96DZ7
CHSVITQDFLTCWLS

TPP1

111

O14773
TSFWLSNTCRLLHCL

MYO5B

1546

Q9ULV0
LSFWLSNTCHFLNCL

MYO5C

1441

Q9NQX4